Logo image of NPV

NUVEEN VA QLTY MUNI INC (NPV) Stock Price, Quote, News and Overview

NYSE:NPV - New York Stock Exchange, Inc. - US67064R1023 - Currency: USD

11.11  +0.01 (+0.09%)

Fundamental Rating

1

NPV gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of NPV have multiple concerns. NPV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NPV had positive earnings in the past year.
NPV Yearly Net Income VS EBIT VS OCF VS FCFNPV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

Industry RankSector Rank
ROA 1.72%
ROE 2.91%
ROIC 1.5%
ROA(3y)-1.05%
ROA(5y)N/A
ROE(3y)-2.24%
ROE(5y)N/A
ROIC(3y)1.96%
ROIC(5y)N/A
NPV Yearly ROA, ROE, ROICNPV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5 -10

1.3 Margins

In the last couple of years the Operating Margin of NPV has declined.
NPV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 44.36%
PM (TTM) 40.73%
GM 45.72%
OM growth 3Y-5.54%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.31%
GM growth 5YN/A
NPV Yearly Profit, Operating, Gross MarginsNPV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 100 -100

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for NPV remains at a similar level compared to 1 year ago.
NPV has a worse debt/assets ratio than last year.
NPV Yearly Shares OutstandingNPV Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
NPV Yearly Total Debt VS Total AssetsNPV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

NPV has an Altman-Z score of 0.71. This is a bad value and indicates that NPV is not financially healthy and even has some risk of bankruptcy.
NPV has a Debt/Equity ratio of 0.67. This is a neutral value indicating NPV is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 0.71
ROIC/WACCN/A
WACCN/A
NPV Yearly LT Debt VS Equity VS FCFNPV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.3 Liquidity

NPV has a Current Ratio of 0.07. This is a bad value and indicates that NPV is not financially healthy enough and could expect problems in meeting its short term obligations.
NPV has a Quick Ratio of 0.07. This is a bad value and indicates that NPV is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
NPV Yearly Current Assets VS Current LiabilitesNPV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 114.04% over the past year.
NPV shows a small growth in Revenue. In the last year, the Revenue has grown by 3.89%.
Measured over the past years, NPV shows a decrease in Revenue. The Revenue has been decreasing by -0.31% on average per year.
EPS 1Y (TTM)114.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.81%
Revenue 1Y (TTM)3.89%
Revenue growth 3Y-0.31%
Revenue growth 5YN/A
Sales Q2Q%2.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NPV Yearly Revenue VS EstimatesNPV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.74, the valuation of NPV can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 28.87, NPV is valued at the same level.
Industry RankSector Rank
PE 31.74
Fwd PE N/A
NPV Price Earnings VS Forward Price EarningsNPV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NPV Per share dataNPV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.14%, NPV is a good candidate for dividend investing.
NPV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 7.14%

5.2 History

NPV has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of NPV decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
NPV Yearly Dividends per shareNPV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NPV Yearly Income VS Free CF VS DividendNPV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 0 10M -10M 20M -20M

More info and screens

NUVEEN VA QLTY MUNI INC

NYSE:NPV (4/28/2025, 8:28:03 PM)

11.11

+0.01 (+0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)08-04 2025-08-04
Inst Owners9.18%
Inst Owner Change1.44%
Ins OwnersN/A
Ins Owner Change0%
Market Cap202.76M
Analysts45
Price TargetN/A
Short Float %0.2%
Short Ratio1.18
Dividend
Industry RankSector Rank
Dividend Yield 7.14%
Yearly Dividend0.51
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.072)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 31.74
Fwd PE N/A
P/S 13.03
P/FCF N/A
P/OCF N/A
P/B 0.93
P/tB 0.93
EV/EBITDA N/A
EPS(TTM)0.35
EY3.15%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.85
BVpS11.94
TBVpS11.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.72%
ROE 2.91%
ROCE 2%
ROIC 1.5%
ROICexc 1.5%
ROICexgc 1.5%
OM 44.36%
PM (TTM) 40.73%
GM 45.72%
FCFM N/A
ROA(3y)-1.05%
ROA(5y)N/A
ROE(3y)-2.24%
ROE(5y)N/A
ROIC(3y)1.96%
ROIC(5y)N/A
ROICexc(3y)1.96%
ROICexc(5y)N/A
ROICexgc(3y)1.96%
ROICexgc(5y)N/A
ROCE(3y)2.63%
ROCE(5y)N/A
ROICexcg growth 3Y-2.35%
ROICexcg growth 5YN/A
ROICexc growth 3Y-2.36%
ROICexc growth 5YN/A
OM growth 3Y-5.54%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.31%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 0.71
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.89%
Revenue growth 3Y-0.31%
Revenue growth 5YN/A
Sales Q2Q%2.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.47%
EBIT growth 3Y-5.83%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y114.94%
FCF growth 3Y63.4%
FCF growth 5YN/A
OCF growth 1Y114.94%
OCF growth 3Y63.4%
OCF growth 5YN/A